Breathing Hydrogen-Oxygen Mixture Decreases Inspiratory Effort in Patients with Tracheal Stenosis.
Zi-Qing Zhou, Chang-Hao Zhong, Zhu-Quan Su, Xiao-Ying Li, Yu Chen, Xiao-Bo Chen, Chun-Li Tang, Lu-Qian Zhou, Shi-Yue Li · Respiration; international review of thoracic diseases · 2019
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In 35 patients with severe acute tracheal stenosis were recruited in this prospective self-control study, the mean reduction in the EMGdi under H₂-O₂ was 10.53 ± 6.83%. These findings add human evidence supporting molecular hydrogen's therapeutic potential across the specific human outcomes evaluated in this study.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen affected the outcomes measured in 35 patients with severe acute tracheal stenosis were recruited in this prospective self-control study. The mean reduction in the EMGdi under H₂-O₂ was 10.53 ± 6.83%.
What the Researchers Studied
The researchers studied 35 patients with severe acute tracheal stenosis were recruited in this prospective self-control study. The study used a human clinical study. The comparison condition was control condition or baseline measurements.
What Effects Did Molecular Hydrogen Have?
Reported treatment duration: 15 min. The mean reduction in the EMGdi under H₂-O₂ was 10.53 ± 6.83%. The authors concluded that breathing H₂-O₂ may reduce the inspiratory effort in patients with acute severe tracheal stenosis and can be used for this purpose safely.
Why These Findings Matter
These findings add human evidence supporting molecular hydrogen's therapeutic potential across the specific human outcomes evaluated in this study and contribute to the growing body of molecular-hydrogen research.
How Strong Is This Evidence?
This is human clinical evidence from a human clinical study. H2HUBB interprets the findings in the context of the study design, sample, comparator, and measured outcomes rather than using one publication as a verdict on hydrogen therapy.
Technical Study Details
H2HUBB classifies this publication as human clinical study with human clinical evidence. The research population or model was 35 patients with severe acute tracheal stenosis were recruited in this prospective self-control study. The study used a human clinical study. The reported treatment duration was 15 min.
Limitations and Safety
No separate limitations or safety findings were identified in the current-study source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.